High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group (Q47288790)

13 January 2018

title

High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group (English)

1 reference

13 January 2018

1 reference

1 reference

Maier RF

1

1 reference

13 January 2018

Obladen M

2

1 reference

13 January 2018

Kattner E

3

1 reference

13 January 2018

Natzschka J

4

1 reference

13 January 2018

Messer J

5

1 reference

13 January 2018

Regazzoni BM

6

1 reference

13 January 2018

Speer CP

7

1 reference

13 January 2018

Fellman V

8

1 reference

13 January 2018

Grauel EL

9

1 reference

13 January 2018

Groneck P

10

1 reference

13 January 2018

Wagner M

11

1 reference

13 January 2018

Moriette G

12

1 reference

13 January 2018

Salle BL

13

1 reference

13 January 2018

Verellen G

14

1 reference

13 January 2018

Scigalla P

15

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

13 January 2018

The Journal of Pediatrics

published in

1 reference

13 January 2018

volume

132

1 reference

13 January 2018

page(s)

866-870

1 reference

13 January 2018

issue

5

1 reference

13 January 2018

Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Double blind trial of recombinant human erythropoietin in preterm infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Recombinant human erythropoietin in the treatment of anemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

CDC definitions for nosocomial infections, 1988

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

Umbilical cord clamping and preterm infants: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2898%2970320-8

10.1016/S0022-3476(98)70320-8

7 January 2021

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

9602202

1 reference

13 January 2018